Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search


Apto is a company that offers cloud-based CRM and deal management software to help commercial real estate brokers manage their contacts, properties, listings, and deals. Apto is headquartered in Denver, CO.

Apto built a cloud-based customer relationship management (CRM) tool for real estate brokers which allows them to manage their deals; their investment, landlord and tenant pipelines; and their properties and listings.

Venture Capital Round

Apto raised $975,000 in July of 2014. The funding and investors were unannounced.

Series A

Announced in November of 2014, Apto raised $1.4 million in funding from Mercury Fund.

Series B

In August 2015, Apto raised $8 million in funding. Adams Street Partners led the round which included participation from Mercury Fund.

Venture Equity

Found in filings through the SEC, Apto raised $5.9 million in March of 2017, $7.5 million in funding in May of 2017, $2.5 million in June of 2018 and $5 million in October of 2019. None of the investors for any of the rounds were announced.


Apto was founded in 2012 in The Woodlands, TX by Tanner McGraw, a former commercial real estate broker. The company moved its headquarters to Denver from Texas in 2015. Angela Tucci was hired as Chief Executive Officer at Apto in August, 2017. Apto has received investments from Mercury Fund and Adams Street Partners. The company placed on the Inc. 5000 list, as one of the top 5000 fastest-growing private companies in the United States in 2016, 2017, and 2018.


May 2017
Apto raises a $7,500,000 venture round.
August 2016
Apto raises a $47,000 venture round from Mercury Fund.
August 2015
Apto raises a $8,000,000 series B round from Adams Street Partners, Mercury Fund and Service Provider Capital.
November 2014
Apto raises a $1,400,000 series A round from Mercury Fund.
July 2014
Apto raises a $975,000 venture round.

Funding rounds


Further Resources



Vicky Ge Huang
December 28, 2020
Business Insider
Innovation and capital flows into the biotech sector are at all-time-high thanks to COVID-19 vaccine-induced interest and goodwill, according to RBC.


Golden logo
By using this site, you agree to our Terms & Conditions.